Blood Gas Analyzer Market Analysis

  • Report ID: 5645
  • Published Date: Sep 16, 2025
  • Report Format: PDF, PPT

Blood Gas Analyzer Market Segmentation:

Modality Segment Analysis

Based on modality, the portable segment in the blood gas analyzer market is anticipated to hold the largest revenue share of 80% by the end of 2035. The portable gadgets have a higher adoption rate because they are simple to use, and manage, and need little upkeep. Numerous businesses are contributing to the creation and promotion of these goods. The segment is expanding due in part to an increase in product launches and partnerships. At MEDICA 2021, Boditech Med unveiled the AFIAS-10 immunoassay analyzer with a blood collection tube, which has an all-in-one cartridge system. A special integrated Sample-to-Answer system called the AFIAS-10 can run 10 tests in parallel for every parameter. Using automatic blood tube sample collection, AFIAS-10 offers a dependable test result with a fast and easy-to-use interface.

End Users Segment Analysis

In terms of end-use, the clinical laboratory segment in the blood gas analyzer market is set to hold the highest CAGR by the end of the forecast period. In the forecast years, this segment of healthcare laboratories is expected to expand at a fast pace. Blood gas analyzers are typically larger, benchtop instruments that are capable of handling a higher volume of samples and performing a wider range of tests in clinical laboratories.

Our in-depth analysis of the global blood gas analyzer market includes the following segments:

          Product Type

  • i-Stat
  • ePOC
  • GEM Premier
  • ABL Flex
  •  Cobas
  • RAPID Series

          Modality

  • Portable
  • Bench-top

          End Users

  • Hospital
  • Diagnostics Centers
  • Clinical Labs
  •  Ambulatory Surgical Centers
  • Educational Institutes

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of blood gas analyzer is estimated at USD 704.12 million.

The global blood gas analyzer market size crossed USD 674.96 million in 2025 and is likely to expand at a CAGR of around 4.8%, surpassing USD 1.08 billion revenue by 2035.

North America blood gas analyzer market dominates with an 80% share by 2035, fueled by rising healthcare costs and rapid adoption of new medical technology.

Key players in the market include Medica Corporation, ERBA Diagnostics Inc., F. Hoffmann-La Roche Ltd., Sysmex America Inc., Bio-Rad Laboratories.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos